Relief Therapeutics Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.9%.

Top 18 shareholders own 39.99% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
23%	Global Emerging Markets	2,889,748	CHF3.6m	0%	28.49%
8.96%	Goldman Sachs Group, Investment Banking and Securities Investments	1,123,144	CHF1.4m	0%	no data
5.49%	Armistice Capital LLC	688,000	CHF860.0k	-28.3%	0.03%
0.73%	Credit Suisse Asset Management (Switzerland) Ltd.	91,967	CHF115.0k	0%	no data
0.62%	Paolo Galfetti	78,094	CHF97.6k	0%	no data
0.46%	UBS Asset Management AG	57,416	CHF71.8k	0%	no data
0.2%	ZKB Asset Management	25,363	CHF31.7k	0%	no data
0.19%	Zürcher Kantonalbank, Investment Arm	23,891	CHF29.9k	0%	no data
0.17%	Pictet Asset Management Limited	21,076	CHF26.3k	0%	no data
0.042%	BlackRock, Inc.	5,214	CHF6.5k	0%	no data
0.036%	British & American Investment Trust PLC	4,540	CHF5.7k	0%	0.08%
0.028%	Lombard Odier Asset Management (Switzerland) SA	3,493	CHF4.4k	0%	no data
0.01%	Thomas Plitz	1,250	CHF1.6k	0%	no data
0.0037%	Jack Weinstein	463	CHF578.4	0%	no data
0.0034%	State Street Global Advisors, Inc.	433	CHF540.8	0%	no data
0.0028%	Jeremy Meinen	352	CHF440.5	0%	no data
0.0028%	Patrice Jean	350	CHF437.3	0%	no data
0.0001%	Strategic Investment Solutions, Inc.	12	CHF15.7	0%	no data